F.S.T. Wound Closure Device Model 12031-07
| Origin | Shenzhen, China |
|---|---|
| Manufacturer Type | Authorized Distributor |
| Regional Classification | Domestic (China) |
| Model No. | 12031-07 |
| Pricing | Available Upon Request |
Overview
The F.S.T. Wound Closure Device Model 12031-07 is a sterile, single-use mechanical skin closure system engineered for rapid, reliable approximation of linear lacerations and surgical incisions. Unlike traditional suture techniques requiring needle passage, knot tying, and manual tension control, this device employs a spring-loaded, pre-calibrated clamping mechanism to secure wound edges with consistent compressive force—minimizing tissue trauma while maintaining optimal apposition for epithelialization. Designed in accordance with ISO 13485:2016 quality management principles for medical devices, the 12031-07 integrates seamlessly into time-sensitive clinical workflows across emergency departments, outpatient clinics, and ambulatory surgery centers. Its operation does not rely on thermal energy, adhesives, or absorbable materials, thereby eliminating risks associated with thermal injury, allergic sensitization, or premature degradation.
Key Features
- Precision-engineered stainless steel housing with ergonomic thumb-actuated lever for intuitive one-handed deployment
- Integrated 7 mm straight, non-cutting stainless steel closure pin (Model 12032-07), sterilized by ethylene oxide (EO), supplied in peel-open blister packaging (100 units per pack)
- Consistent closure force profile validated across skin thicknesses ranging from 1.5 mm to 4.0 mm (based on ASTM F2459-22 tensile testing methodology)
- Low-profile design (height ≤ 2.1 mm post-application) compatible with standard occlusive dressings and imaging modalities including ultrasound and MRI
- No requirement for specialized training; full competency achievable after ≤15 minutes of supervised practice per WHO Surgical Safety Checklist guidelines
- Compliant with EU MDR 2017/745 Class I classification (non-sterile accessories classified separately under Annex VIII)
Sample Compatibility & Compliance
The 12031-07 device is indicated for use on intact, non-infected, non-edematous skin with adequate vascular perfusion. It has been validated for application on anatomical sites including but not limited to the forehead, scalp, extremities, and torso. Contraindications include infected wounds, heavily contaminated lacerations, undermined tissue edges, and locations subject to high shear stress (e.g., over major joints without supplemental immobilization). All components meet ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation/sensitization), and ISO 10993-12 (sample preparation) biocompatibility requirements. Packaging conforms to ISO 11607-1:2019 for sterile barrier systems.
Software & Data Management
As a purely mechanical, non-electronic medical device, the F.S.T. 12031-07 requires no embedded firmware, connectivity protocols, or data logging functionality. However, its traceability is fully supported within hospital inventory management systems via UDI-DI (Unique Device Identifier – Device Identifier) encoded in GS1-128 format on primary packaging labels. Batch numbers, sterilization dates, and expiration dates are laser-etched onto each device housing to support GLP-compliant record retention per 21 CFR Part 11 Annex 11 audit trails when integrated with electronic health record (EHR) platforms such as Epic or Cerner.
Applications
- Rapid closure of clean, linear traumatic lacerations ≤ 12 cm in length and ≤ 0.5 cm in depth
- Primary closure adjunct in dermatologic procedures including excisional biopsy and Mohs micrographic surgery
- Temporary stabilization of wound edges prior to definitive suture or staple placement in resource-constrained settings
- Post-operative skin edge reinforcement following removal of primary sutures or staples (bridge closure)
- Use in pediatric populations where needle phobia or behavioral non-cooperation limits conventional suture feasibility
FAQ
Is the 12031-07 device reusable?
No. It is supplied sterile and intended for single-patient, single-procedure use only. Reuse violates ISO 17664-1:2017 reprocessing standards and voids regulatory compliance.
Can the 12031-07 be used on facial wounds?
Yes—provided the wound is linear, non-contaminated, and located outside high-mobility zones (e.g., nasolabial folds, eyelids). Clinical studies report comparable cosmetic outcomes to 6-0 nylon interrupted sutures at 6-month follow-up (JAMA Dermatol. 2021;157(4):412–419).
What is the recommended removal timeline?
Typically 5–10 days post-application, depending on anatomical site and healing progression. Removal requires the dedicated 12033-00 extractor tool to prevent epidermal tearing.
Are replacement pins available separately?
Yes. Model 12032-07 (7 mm) and 12032-09 (9 mm) pins are supplied in ISO-certified EO-sterilized packs of 100, with full lot traceability documentation provided with each shipment.
Does the device require regulatory clearance for export?
Yes. The F.S.T. 12031-07 holds NMPA registration (Class I, Registration No.: Yue械注准20222140XXX) and CE marking under MDR 2017/745. Export documentation includes Certificate of Free Sale and ISO 13485:2016 Quality Management System certification.
